---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295258079.md"
description: "X4 Pharmaceuticals shares are trading higher after the company reported better-than-expected Q2 financial results."
datetime: "2026-08-07T16:04:49.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295258079.md)
  - [en](https://longbridge.com/en/news/295258079.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295258079.md)
---

# 

X4 Pharmaceuticals shares are trading higher after the company reported better-than-expected Q2 financial results.

### Related Stocks

- [XFOR.US](https://longbridge.com/en/quote/XFOR.US.md)

## Related News & Research

- [X4 Pharmaceuticals (XFOR) to Release Quarterly Earnings on Thursday](https://longbridge.com/en/news/294330509.md)
- [X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Receives Average Rating of "Moderate Buy" from Analysts](https://longbridge.com/en/news/293817193.md)
- [13:41 ETNorgine anuncia la autorización de comercialización de la Comisión Europea para XOLREMDI® (mavorixafor)](https://longbridge.com/en/news/284619445.md)
- [X4 Pharmaceuticals (NASDAQ:XFOR) Releases Earnings Results, Beats Expectations By $0.05 EPS](https://longbridge.com/en/news/295157811.md)
- [X4 Pharmaceuticals Q2 FY26 net loss narrows to $16.2 million; revenue rises to $8.81 million](https://longbridge.com/en/news/295148953.md)